CClinicalTrials.gg
CompletedNCT01757600Updated Dec 31, 2012

Microperimetry and Optical Coherence Tomography (OCT) in Idiopathic Macular Hole

An observational study in Macular Hole, sponsored by Centre Hospitalier Universitaire Dijon. Completed at 1 site in France. Open to participants aged 55 Years to 85 Years. Per ClinicalTrials.gov, last updated 2012-12-31.

Sponsored by Centre Hospitalier Universitaire Dijon · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
23
Ages
55 Years to 85 Years
Sex
All
01

Study summary

To evaluate the correlations between anatomical and functional changes studied with microperimetry (MPM) and spectral-domain OCT (SD-OCT) in patients after successful repair of idiopathic macular hole (MH).

02

Conditions studied

  • Macular Hole

Browse trials for

03

In context

Retinal Perforations

156 studies on the registry are indexed under Retinal Perforations; 21 are open to participants now.

This study's enrollment of 23 is below the median of 42 across 51 observational studies indexed under Retinal Perforations.

Browse Retinal Perforations studies →

Lead sponsor

Centre Hospitalier Universitaire Dijon is the lead sponsor of 495 studies on the registry; 105 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who underwent successful surgery for MH defined as closure of the hole, at least 1 year before.

Inclusion criteria

  • Closure of the hole seen on the OCT at 1 year postoperative

Exclusion criteria

Exclusion Criteria:

  • Patients with an axial length over 26 mm, diabetes, macular diseases, glaucoma, or postoperative retinal detachment were excluded
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
23 participants (actual)
Patient registry
No

Groups and cohorts

  • Macular Hole

    Other: Microperimetry

Interventions

  • OtherMicroperimetry
06

What researchers measure

Primary outcomes

  1. Macular sensitivity

    To describre mean retinal sensitivity in the 12 and 4 central degrees of the retina in 23 patients one-year after macular hole surgery and thus to correlate macular sensitivities and retinal anatomic features in SD-OCT

    Time frame: 12 months

07

Study locations

1 site
  • Ophthalmology Department CHU Dijon
    Dijon, Burgundy 21000, France
08

References and documents

Publications

  • Bonnabel A, Bron AM, Isaico R, Dugas B, Nicot F, Creuzot-Garcher C. Long-term anatomical and functional outcomes of idiopathic macular hole surgery. The yield of spectral-domain OCT combined with microperimetry. Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2505-11. doi: 10.1007/s00417-013-2339-y. Epub 2013 Apr 26. PubMed 23620091 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 31, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01757600
Lead sponsor
Centre Hospitalier Universitaire Dijon
Responsible party
Nicot Frederic (Head of research unit in Ophthalmology department, Centre Hospitalier Universitaire Dijon) — Principal investigator
First posted
Dec 31, 2012
Start date
Aug 2010
Primary completion
Nov 2010
Last update
Dec 31, 2012
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion